Skip to main content
. Author manuscript; available in PMC: 2021 Nov 11.
Published in final edited form as: Br J Haematol. 2021 Feb 3;192(4):761–768. doi: 10.1111/bjh.17311

Table III.

Viral reactivations post-transplant.

Type n (%)
CMV reactivation requiring treatment 11 (9%)
CMV IgG status (recipient/donor) Positive/positive 8
Positive/negative 3
EBV reactivation requiring treatment 1 (1%)
HSV infection or reactivation 2 (1·6%)
VZV reactivation 12 (9·8%)
BK viruria 1 (1%)

CMV, cytomegalovirus; EBV, Epstein–Barr virus; HSV, herpes simplex virus; VZV, varicella zoster virus.